Want to join the conversation?
Biotechnology company $CELG reported a decline in 4Q15 earnings due to higher income tax provision. Net income fell to $561MM or $0.69 per share from $613.9MM or $0.74 per share last year. Revenue grew to $2.56Bil from $2.09Bil. Adjusted EPS increased to $1.18 from $1.01.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.